Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma.
Vilain, Ricardo E
Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Sep 2017 - 5024-5033 p. digital
Publication Type: Journal Article
1557-3265
10.1158/1078-0432.CCR-16-0698 doi
Adult
Aged
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized--administration & dosage
B7-H1 Antigen--antagonists & inhibitors
Biomarkers, Tumor--genetics
Biopsy
CD8-Positive T-Lymphocytes--immunology
Drug Resistance, Neoplasm--genetics
Female
Gene Expression Regulation, Neoplastic
Humans
Immunotherapy
Kaplan-Meier Estimate
Lymphocytes, Tumor-Infiltrating--drug effects
Male
Melanoma--drug therapy
Middle Aged
Nivolumab
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Sep 2017 - 5024-5033 p. digital
Publication Type: Journal Article
1557-3265
10.1158/1078-0432.CCR-16-0698 doi
Adult
Aged
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized--administration & dosage
B7-H1 Antigen--antagonists & inhibitors
Biomarkers, Tumor--genetics
Biopsy
CD8-Positive T-Lymphocytes--immunology
Drug Resistance, Neoplasm--genetics
Female
Gene Expression Regulation, Neoplastic
Humans
Immunotherapy
Kaplan-Meier Estimate
Lymphocytes, Tumor-Infiltrating--drug effects
Male
Melanoma--drug therapy
Middle Aged
Nivolumab
Programmed Cell Death 1 Receptor--antagonists & inhibitors